Chinese CardiologistsNCT06991088
Chinese Cardiologists' Knowledge/Practices on Flu Vaccine for Chronic Coronary Syndrome
An observational study of Chinese Cardiologists, run by The Affiliated Hospital of Hangzhou Normal University at 1 site in China.
Trial summary
This long-term single-center cross-sectional study evaluates physicians' knowledge of influenza vaccination in CCS patients through collected feedback, while identifying knowledge gaps and misconceptions regarding vaccination. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Chinese Cardiologists
- Type of treatment
- Vaccines
- How many people
- 5,000 participants
- Where
- 1 siteChina
- Study dates
- Jun 2025to May 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Responses from cardiologists across various regions, age groups, professional titles, and experience levels in China, as collected in the survey.
Who may be able to join
- Cardiologists (licensed practitioners) with specialized knowledge of the association between influenza vaccination and cardiovascular diseases.
Who cannot join
- Physicians from non-cardiology specialties (e.g., surgery, general internal medicine [including respiratory and gastroenterology departments], emergency medicine).
- Physicians unable to complete the questionnaire survey.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
MingWei Wang
Hanzhou, Zhejiang, 310000
MingWei W Wang, PhD, 86-18758871517 ext. NOT, wmw990556@163.com
About this study
Official title: Research on the Cognition and Practices of Chinese Cardiologists Regarding Influenza Vaccination for Patients With Chronic Coronary Syndrome
This long-term single-center cross-sectional study evaluates physicians' knowledge of influenza vaccination in CCS patients through collected feedback, while identifying knowledge gaps and misconceptions regarding vaccination. By analyzing factors influencing physicians' recommendation practices, it provides evidence to guide future educational and policy interventions. Ultimately, the study aims to enhance cardiologists' vaccination awareness, thereby optimizing CCS patient management and reducing influenza-associated complications and mortality.
Read the detailed description
This project conducts a comprehensive literature review to examine current research and practices regarding influenza vaccination for chronic coronary syndrome (CCS) patients among cardiologists worldwide. The review provides theoretical support for study design and helps identify potential causes of low vaccination rates among CCS patients in China.Based on research objectives, investigators developed a structured questionnaire covering four key dimensions:Basic demographic information、Knowledge assessment、Clinical practice patterns、Attitudes and recommendations.The survey targets cardiologists from major Chinese hospitals, employing random or stratified sampling to ensure representative sampling. Data collection will be conducted through online and offline questionnaire distribution.Statistical analysis will be performed using SPSS or equivalent software, including:Descriptive statistics、t-tests、Chi-square tests to examine how different background factors influence knowledge and practices.Findings will systematically summarize Chinese cardiologists' current understanding and behavioral patterns regarding influenza vaccination for CCS patients.
- Conditions
- Chinese Cardiologists
- Keywords
- Chronic Coronary Syndrome, Chinese Cardiologists, Knowledge Survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Chief Physician (Professor-level) | Responses from chief physicians (professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. | |
| Associate Chief Physician (Associate Professor-level) | Responses from Associate Chief Physician (Associate Professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. | |
| Attending Physician | Responses from Attending Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. | |
| Resident Physician | Responses from chief Resident Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. |
What is being measured
The primary outcome is the main question the study is designed to answer.
cognitive status
Based on a survey on "Cardiologists' Knowledge and Behavior Regarding Influenza Vaccination for Patients with Chronic Coronary Syndrome in China," regular follow-up will be conducted. The scale scores will be further improved in subsequent research.
Measured: baseline and 1-year later
practical situation
Based on a survey on "Cardiologists' Knowledge and Behavior Regarding Influenza Vaccination for Patients with Chronic Coronary Syndrome in China," regular follow-up will be conducted. The scale scores will be further improved in subsequent research.
Measured: baseline and 1-year later
attitude
Based on a survey on "Cardiologists' Knowledge and Behavior Regarding Influenza Vaccination for Patients with Chronic Coronary Syndrome in China," regular follow-up will be conducted. The scale scores will be further improved in subsequent research.
Measured: baseline and 1-year later
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 May 2025
- Study startJun 2025 (estimated)
- Primary completionJul 2026 (estimated)
- Study completionMay 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chinese CardiologistsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 5,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The Affiliated Hospital of Hangzhou Normal University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06991088
- Sponsor's protocol ID
- AH-2025-001
- Status last verified
- May 2025
- First submitted
- 19 May 2025
- Last updated
- 4 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Research on the Cognition and Practices of Chinese Cardiologists Regarding Influenza Vaccination for Patients With Chronic Coronary Syndrome
- ClinicalTrials.gov ID
- NCT06991088
- Acronym / sponsor ID
- AH-2025-001
- Conditions
- Chinese Cardiologists
- Keywords
- Chronic Coronary Syndrome, Chinese Cardiologists, Knowledge Survey
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- The Affiliated Hospital of Hangzhou Normal UniversityUniversity, hospital or other
- Study start
- Jun 2025 (estimated)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- May 2027 (estimated)
- First posted
- 25 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This long-term single-center cross-sectional study evaluates physicians' knowledge of influenza vaccination in CCS patients through collected feedback, while identifying knowledge gaps and misconceptions regarding vaccination. By analyzing factors influencing physicians' recommendation practices, it provides evidence to guide future educational and policy interventions. Ultimately, the study aims to enhance cardiologists' vaccination awareness, thereby optimizing CCS patient management and reducing influenza-associated complications and mortality.
Detailed description
This project conducts a comprehensive literature review to examine current research and practices regarding influenza vaccination for chronic coronary syndrome (CCS) patients among cardiologists worldwide. The review provides theoretical support for study design and helps identify potential causes of low vaccination rates among CCS patients in China.Based on research objectives, investigators developed a structured questionnaire covering four key dimensions:Basic demographic information、Knowledge assessment、Clinical practice patterns、Attitudes and recommendations.The survey targets cardiologists from major Chinese hospitals, employing random or stratified sampling to ensure representative sampling. Data collection will be conducted through online and offline questionnaire distribution.Statistical analysis will be performed using SPSS or equivalent software, including:Descriptive statistics、t-tests、Chi-square tests to examine how different background factors influence knowledge and practices.Findings will systematically summarize Chinese cardiologists' current understanding and behavioral patterns regarding influenza vaccination for CCS patients.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Chief Physician (Professor-level) | – | –Responses from chief physicians (professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. |
| Associate Chief Physician (Associate Professor-level) | – | –Responses from Associate Chief Physician (Associate Professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. |
| Attending Physician | – | –Responses from Attending Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. |
| Resident Physician | – | –Responses from chief Resident Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Responses from cardiologists across various regions, age groups, professional titles, and experience levels in China, as collected in the survey.
Key inclusion criteria (1 listed)
- Cardiologists (licensed practitioners) with specialized knowledge of the association between influenza vaccination and cardiovascular diseases.
Key exclusion criteria (2 listed)
- Physicians from non-cardiology specialties (e.g., surgery, general internal medicine [including respiratory and gastroenterology departments], emergency medicine).
- Physicians unable to complete the questionnaire survey.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
cognitive status
Time frame: baseline and 1-year later
Based on a survey on "Cardiologists' Knowledge and Behavior Regarding Influenza Vaccination for Patients with Chronic Coronary Syndrome in China," regular follow-up will be conducted. The scale scores will be further improved in subsequent research.
practical situation
Time frame: baseline and 1-year later
Based on a survey on "Cardiologists' Knowledge and Behavior Regarding Influenza Vaccination for Patients with Chronic Coronary Syndrome in China," regular follow-up will be conducted. The scale scores will be further improved in subsequent research.
attitude
Time frame: baseline and 1-year later
Based on a survey on "Cardiologists' Knowledge and Behavior Regarding Influenza Vaccination for Patients with Chronic Coronary Syndrome in China," regular follow-up will be conducted. The scale scores will be further improved in subsequent research.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2025.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chinese Cardiologists, run by The Affiliated Hospital of Hangzhou Normal University at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mingwei W Wang, PhD (18758871517 ext. not, wmw990556@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
cognitive status (time frame: baseline and 1-year later). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2025.